En Carta Diagnostics vs Visby Medical

En Carta Diagnostics vs Visby Medical, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: En Carta Diagnostics is on 52/100 and Visby Medical on 58/100.

En Carta Diagnostics logo
En Carta DiagnosticsDeveloping a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.
Try En Carta Diagnostics
Visby Medical logo
Visby MedicalVisby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.
Try Visby Medical

Where each one leads

En Carta Diagnostics

Leads on none of the measures we hold for both companies.

Visby Medical

  • our overall score: 58/100 against 52/100
  • domain rating: 52/100 against 0/100
  • headcount: 179 against 12
  • funding raised: $331M against $5.0M
  • LinkedIn following: 15,208 against 2,091

At a glance

MeasureEn Carta DiagnosticsVisby Medical
What it isDeveloping a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.
CategoryBiotechnology, HealthTech, Diagnostics, Medical DevicesHealthcare, MedTech, HealthTech, Diagnostics
Sells toBusiness modelB2B2CB2B
OfferingHardwareHardware
Founded20222012
HeadquartersParis, FranceSan Jose, United States
StatusInactiveActive

Size, funding and growth

MeasureEn Carta DiagnosticsVisby Medical
Employees12179
Headcount growthLast 12 monthsNot published-6.5%
Total funding$5.0M$331M
Latest roundSeedSeries E
ValuationNot published$1.0B
LinkedIn followers2,09115,208

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureEn Carta DiagnosticsVisby Medical
StartupHub scoreOur 0-100 rating52/10058/100
Traction45/10060/100
Team70/10030/100
Search visibility20/10037/100
Quality58/10065/100
Agent readinessHow well an AI agent can read and act on the siteNot publishedC (60/100)
Domain ratingLink authority, 0-1000/10052/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureEn Carta DiagnosticsVisby Medical
CDNNot detectedCloudflare
CMSNot detectedShopify
FrameworksNot detectedJquery, Bootstrap
AnalyticsNot detectedGoogle Tag Manager

What users say

MeasureEn Carta DiagnosticsVisby Medical
Reddit sentimentThreads we trackNot published6 positive, 0 negative across 6 threads
Visby Medical
The Visby Medical Women’s Sexual Health Test is a prescription-free test that has received approval from the FDA for an innovative at-home diagnostic solution. This test detects chlamydia, gonorrhea, and trichomoniasis and delivers results
r/EverythingScience

En Carta Diagnostics vs Visby Medical: common questions

Which is better, En Carta Diagnostics or Visby Medical?

On our 0-100 score Visby Medical rates higher (58/100 against 52/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.

How do En Carta Diagnostics and Visby Medical compare on the numbers?

Visby Medical leads on our overall score (58/100 against 52/100), domain rating (52/100 against 0/100), headcount (179 against 12), funding raised ($331M against $5.0M), LinkedIn following (15,208 against 2,091).

What do real users say about En Carta Diagnostics and Visby Medical?

Visby Medical: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/EverythingScience.

Read the full En Carta Diagnostics review and pricing or the Visby Medical review and pricing. You can also browse other En Carta Diagnostics alternatives we track.